MNTS

Momentus Inc. (MNTS) - Q1 2026 10-Q Summary

Business Context and Reporting Period

This Quarterly Report on Form 10-Q covers the period ended March 31, 2026. Momentus Inc. is a U.S. commercial space company providing satellite buses, components, and in-space transportation services. During the quarter, the Company launched its Vigoride 7 Orbital Service Vehicle (OSV) on March 30, 2026, carrying 10 payloads for U.S. government agencies (including NASA, DARPA, and SpaceWERX) and commercial customers. Management has concluded that recent financings have alleviated substantial doubt regarding the Company's ability to continue as a going concern.

Key Financial Metrics

Note: Total debt excludes convertible notes classified as liabilities or equity depending on terms; specific carrying values for convertible notes are detailed in Note 8.

Material Changes vs. Prior Period

• Revenue Growth: Service revenue increased 898% to $3.2 million, driven by $1.6 million in hosted payload services from the Vigoride 7 mission and a $1.4 million increase in engineering project services for NASA and DARPA.
• Expense Increases: Operating expenses rose 62% to $10.5 million. Research and Development (R&D) increased 118% due to higher payroll and subcontractor costs. Selling, General, and Administrative (SG&A) expenses increased 38%, primarily due to a $1.5 million rise in legal expenses.
• Liquidity Improvement: Cash and cash equivalents increased from $12.8 million at year-end 2025 to $23.5 million at March 31, 2026, following significant equity financing activities.
• Debt Restructuring: The Company settled or converted various convertible notes during the quarter, including the May 2025 Convertible Note and partial conversions of SIV Convertible Notes.

Guidance, Outlook, and Risks

Outlook and Capital Resources: Management believes the Company has sufficient resources to fund operations for at least the next twelve months following recent financings, including approximately $16.7 million in net cash from financing activities in Q1 2026 and a subsequent $5.0 million private placement in April 2026. The Company continues to pursue sales of Class A common stock under its At-The-Market (ATM) Sales Agreement.

Risks and Contingencies:

• Litigation: The Company has accrued $2.0 million for probable loss contingencies, including settlements related to founder Lev Khasis ($0.4 million), a Delaware class action insurer claim (ANV Global Services, $1.3 million), and lease restoration costs ($0.3 million).
• Lease Disputes: Ongoing negotiations regarding restoration costs for the vacated San Jose facility, with potential costs estimated between $0.7 million and $0.8 million.
• Operational Risks: Risks include the ability to raise additional capital, obtain government licenses, and successfully execute future missions. The Company faces potential delays in technology development and market adoption.

Key Facts for Investor Verification

• Going Concern Status: Verify the sufficiency of the $23.5 million cash balance against the burn rate of approximately $5.8 million per quarter in operating cash usage.
• Revenue Recognition: Confirm the timing of revenue recognition for the Vigoride 7 mission and the sustainability of government engineering contracts (NASA/DARPA).
• Debt Obligations: Review the terms of remaining convertible notes and the impact of subsequent conversions (April 2026) on share count and dilution.
• Litigation Exposure: Monitor the final settlement amounts for the Khasis and ANV claims, as well as the resolution of the lease restoration dispute.
• Equity Dilution: Assess the impact of the ATM offering and recent private placements on existing shareholder ownership percentages.